Literature DB >> 8108113

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.

J Lukas1, M Pagano, Z Staskova, G Draetta, J Bartek.   

Abstract

Among the key cell cycle regulators, cyclin D1 has been implicated most strongly in oncogenesis. This G1 cyclin is a putative proto-oncogene whose clonal rearrangement and/or amplification and mRNA overexpression occurs in several types of human neoplasias. We have now raised a series of monoclonal antibodies to human cyclin D1 and analysed its regulation at the protein level in 40 human tumour cell lines. We found that 12 cell lines displayed low or undetectable cyclin D1 protein level, while the remaining lines accumulated the protein to a level comparable to, or moderately higher than, that of four normal diploid non-immortalized cell types. The cell cycle-dependent oscillation and subcellular localization of cyclin D1 were similar in both tumour and normal cells. The protein localized to the nucleus of G1 cells, and it was reduced to immunocytochemically undetectable level in DNA-replicating cells. At the functional level, microinjection and electroporation of anti-D1 antibodies revealed that in most tumour cell lines studied, including those with amplification at the cyclin D1 locus, this cyclin is essential for cell cycle progression in G1. Some tumours, however, seem to have evolved mechanism(s) that enable them to bypass the requirement for functional cyclin D1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108113

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  72 in total

1.  Accumulation of cyclin E is not a prerequisite for passage through the restriction point.

Authors:  S V Ekholm; P Zickert; S I Reed; A Zetterberg
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

Authors:  A Sewing; B Wiseman; A C Lloyd; H Land
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway.

Authors:  Yan Li; Wei Yin; Xia Wang; Wenbo Zhu; Yijun Huang; Guangmei Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-06       Impact factor: 11.205

4.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

5.  Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.

Authors:  P J van Diest; R J Michalides; L Jannink; P van der Valk; H L Peterse; J S de Jong; C J Meijer; J P Baak
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

6.  Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16.

Authors:  A Schulze; B Mannhardt; K Zerfass-Thome; W Zwerschke; P Jansen-Dürr
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.

Authors:  G Watanabe; C Albanese; R J Lee; A Reutens; G Vairo; B Henglein; R G Pestell
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

8.  Cell-cycle kinetics of neocortical precursors are influenced by embryonic thalamic axons.

Authors:  C Dehay; P Savatier; V Cortay; H Kennedy
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

9.  Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer.

Authors:  J S de Jong; P J van Diest; R J Michalides; P van der Valk; C J Meijer; J P Baak
Journal:  Mol Pathol       Date:  1998-02

10.  Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit.

Authors:  R M Zwijsen; R Klompmaker; E B Wientjens; P M Kristel; B van der Burg; R J Michalides
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.